Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Organogenesis Holdings (ORGO) Non-Current Receivables (2016 - 2020)

Organogenesis Holdings has reported Non-Current Receivables over the past 5 years, most recently at $302000.0 for Q2 2020.

  • For Q2 2020, Non-Current Receivables fell 41.47% year-over-year to $302000.0; the TTM value through Jun 2020 reached $302000.0, down 41.47%, while the annual FY2019 figure was $556000.0, 16.56% up from the prior year.
  • Non-Current Receivables for Q2 2020 was $302000.0 at Organogenesis Holdings, down from $576000.0 in the prior quarter.
  • Over five years, Non-Current Receivables peaked at $576000.0 in Q1 2020 and troughed at $302000.0 in Q2 2020.
  • A 5-year average of $476400.0 and a median of $486500.0 in 2018 define the central range for Non-Current Receivables.
  • Biggest five-year swings in Non-Current Receivables: increased 16.56% in 2019 and later tumbled 41.47% in 2020.
  • Year by year, Non-Current Receivables stood at $415000.0 in 2016, then fell by 0.48% to $413000.0 in 2017, then grew by 15.5% to $477000.0 in 2018, then grew by 16.56% to $556000.0 in 2019, then plummeted by 45.68% to $302000.0 in 2020.
  • Business Quant data shows Non-Current Receivables for ORGO at $302000.0 in Q2 2020, $576000.0 in Q1 2020, and $556000.0 in Q4 2019.